Financial insights of BCTX

MyFinsight

For the quarter ending 2025-10-31, BCTX made $8,400,826 in revenue. -$8,197,565 in net income. Net profit margin of -97.58%.

Unit: Dollar

Income Statement	2025-10-31
Research and development expenses	6,683,643
General and administrative expenses	1,639,300
Total operating expenses	8,322,943
Operating loss	-8,322,943
Financial income, net	158,646
Change in fair value of the warrant liability	69,201
Share of loss on equity investment	-44,830
Net loss for the period	-8,278,328
Net loss attributable to non-controlling interest	-80,763
Net loss for the period attributable to briacell	-8,197,565

Net loss per share attributable to briacell - basic	-4.35
Net loss per share attributable to briacell - diluted	-4.35
Weighted average number of shares used in computing net basic loss per share of common stock	1,883,906
Weighted average number of shares used in computing net diluted loss per share of common stock	1,883,906